NCT03333707

Brief Summary

The study is designed to examine the efficacy of a mobile application implementation of existing best practices in mental health treatment for managing stress, anxiety, and depression.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for not_applicable anxiety

Timeline
Completed

Started Nov 2017

Shorter than P25 for not_applicable anxiety

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 2, 2017

Completed
Same day until next milestone

Study Start

First participant enrolled

November 2, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 7, 2017

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 10, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 10, 2018

Completed
Last Updated

May 17, 2018

Status Verified

May 1, 2018

Enrollment Period

6 months

First QC Date

November 2, 2017

Last Update Submit

May 16, 2018

Conditions

Outcome Measures

Primary Outcomes (3)

  • Change in Depression

    Change in Patient Health Questionnaire-8 (PHQ-8) score. Range is 0-24. Lower scores indicate less depression.

    2 weeks, 1 month, 3 months

  • Change in Anxiety

    Change in Generalized Anxiety Disorder-7 (GAD-7) score. Range is 0-19. Lower scores indicate less anxiety.

    2 weeks, 1 month, 3 months

  • Change in Depression, Anxiety, Stress

    Change in Depression Anxiety Stress Scale-21 (DASS-21) score. We will look at subscales. Ranges for depression, anxiety, and stress are 0-28, 0-20, and 0-33, respectively. Lower scores indicate less severity.

    2 weeks, 1 month, 3 months

Secondary Outcomes (1)

  • Change in Self-Efficacy

    2 weeks, 1 month, 3 months

Study Arms (2)

Active

EXPERIMENTAL

Participants will be provided will full access to the Pacifica app.

Behavioral: Pacifica App

Wait List

NO INTERVENTION

Participants will be placed on a wait list and will receive access to the app after 1 month.

Interventions

Pacifica AppBEHAVIORAL

The app contains several activities which are digital implementations of standard psychotherapy practices. Users may select which app elements they would like to use, and when. These app elements include relaxation and meditation activities, tools to examine your thoughts or self-talk, goal setting lists, and mood and health ratings. The app also has a peer support community where users can communicate with others who are having similar experiences. There is no minimum requirement for amount of time spent on any given activity, or in the app in total. The commercially available app has a feature to connect users to their existing healthcare providers, but this feature will not be available to study participants. Study participants may continue to see their existing providers.

Active

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Target disease: participants who score between 5 and 14 on the GAD-7 OR between 5 and 14 on the PHQ-8 and are therefore believed to be experience mild to moderate depression or anxiety
  • No previous experience using the Pacifica app.
  • Regular access to a smartphone
  • Fluent in English
  • Living in U.S.

You may not qualify if:

  • Below 5 or over 14 on GAD-7 or below 5 or over 14 on PHQ-8
  • Positive response on screener of presence of diagnosis of bipolar disorder, schizophrenia, other psychotic spectrum disorder, organic brain disease, currently pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pacifica Labs, Inc.

San Francisco, California, 94110, United States

Location

Related Publications (1)

  • Moberg C, Niles A, Beermann D. Guided Self-Help Works: Randomized Waitlist Controlled Trial of Pacifica, a Mobile App Integrating Cognitive Behavioral Therapy and Mindfulness for Stress, Anxiety, and Depression. J Med Internet Res. 2019 Jun 8;21(6):e12556. doi: 10.2196/12556.

MeSH Terms

Conditions

Anxiety DisordersDepression

Condition Hierarchy (Ancestors)

Mental DisordersBehavioral SymptomsBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 2, 2017

First Posted

November 7, 2017

Study Start

November 2, 2017

Primary Completion

May 10, 2018

Study Completion

May 10, 2018

Last Updated

May 17, 2018

Record last verified: 2018-05

Data Sharing

IPD Sharing
Will not share

Individual data will not shared.

Locations